Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Carboxypeptidase G2

EU orphan designation number: EU/3/02/128   
Active ingredient: Carboxypeptidase G2
Indication: Adjunctive treatment in patients at risk of methotrexate toxicity
Sponsor: Protherics Plc
The Health Business and Technical Park, Runcorn, Cheshire WA7 4 QF, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/02/2003 Centralised Orphan - Designation EMEA/OD/049/02 (2003)471 of 03/02/2003
16/12/2004 Centralised Orphan - Transfer of orphan designation EMEA/OD/049/02/T/01 (2004)4830 of 15/12/2004